Overview
- The proposed five‑year memorandum would have provided $367 million for HIV/AIDS, tuberculosis, malaria, maternal and child health, and outbreak preparedness.
- Government spokesperson Nick Mangwana said the offer required long‑term access to biological samples and epidemiological data without reciprocal data sharing or assured access to vaccines, diagnostics, or treatments.
- President Emmerson Mnangagwa directed negotiators to terminate the talks, reversing earlier engagement by the health and finance ministers.
- Public health groups, including the Zimbabwe College of Public Health Physicians and ZNNP+, warned that a rapid pullback could disrupt treatment for 1.2 million people on U.S.-supported HIV therapy and increase transmission and drug resistance.
- Zimbabwe also announced an immediate suspension of exports of raw minerals and lithium concentrates as the dispute extended into economic policy.